LeMaitre Vascular Other Stockholder Equity Over Time
| LMAT Stock | USD 105.43 1.66 1.55% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out LeMaitre Vascular Performance and LeMaitre Vascular Correlation. LeMaitre |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LeMaitre Vascular. If investors know LeMaitre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LeMaitre Vascular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.485 | Dividend Share 0.62 | Earnings Share 1.82 | Revenue Per Share 9.512 | Quarterly Revenue Growth 0.156 |
The market value of LeMaitre Vascular is measured differently than its book value, which is the value of LeMaitre that is recorded on the company's balance sheet. Investors also form their own opinion of LeMaitre Vascular's value that differs from its market value or its book value, called intrinsic value, which is LeMaitre Vascular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LeMaitre Vascular's market value can be influenced by many factors that don't directly affect LeMaitre Vascular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LeMaitre Vascular's value and its price as these two are different measures arrived at by different means. Investors typically determine if LeMaitre Vascular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LeMaitre Vascular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Stockholder Equity Analysis
Compare LeMaitre Vascular and related stocks such as InfuSystems Holdings, Pro Dex, and Utah Medical Products Other Stockholder Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INFU | 8.4 M | 87.5 M | 88.7 M | 89.8 M | 90.2 M | 119.1 M | 126.4 M | 131.2 M | 125.2 M | 83.7 M | 84.8 M | 101.9 M | 105.9 M | 109.8 M | 102.4 M |
| PDEX | 500 K | (16.8 B) | 7.1 M | 7.6 M | 7.4 M | 7.8 M | 7.8 M | 6.6 M | 451 K | 414 K | 215 K | 0.0 | 0.0 | 0.0 | 0.0 |
| UTMD | 6.3 M | 722 K | 2.3 M | 3.3 M | 2.9 M | 2.7 M | 378 K | 809 K | 122 K | 17 K | 115 K | 841 K | 251 K | 594 K | 564.3 K |
| MLSS | 6.7 M | 63.2 M | 64.1 M | 66.2 M | 77 M | 78.3 M | 82.5 M | 86.5 M | 88.3 M | 95.2 M | 117 M | 124 M | 126.6 M | 131.3 M | 72.6 M |
| HOLX | 600 K | 5.4 B | 5.5 B | 5.7 B | 5.6 B | 5.3 B | 5.2 B | 4.9 B | 5 B | 4.3 B | 4 B | 3.5 B | 3.1 B | 5.1 B | 2.6 B |
| HAE | 58.9 M | 324.9 M | 365 M | 404.3 M | 427 M | 438.3 M | 482 M | 504 M | 536.3 M | 553.2 M | 602.7 M | 572.5 M | 594.7 M | 634.6 M | 666.4 M |
| ICUI | 10.9 M | 21.4 M | 48.6 M | 78.4 M | 107.3 M | 145.1 M | 162.8 M | 625.6 M | 657.8 M | 668.8 M | 693 M | 721.4 M | 1.3 B | 1.4 B | 1.4 B |
| NVST | 5 B | 5 B | 5 B | 5 B | 5 B | 5 B | 5 B | 5 B | 4.9 B | 3.6 B | 3.7 B | 3.7 B | 3.7 B | 3.8 B | 3.2 B |
| COO | 119.2 M | 1.2 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.1 B | 1.2 B | 1 B | 1 B | 1.1 B | 1.1 B | 1.1 B | 1.3 B | 694.7 M |
| KRMD | 1.9 M | 3.1 M | 3.2 M | 3.3 M | 3.6 M | 3.7 M | 3.8 M | 3.9 M | 4.3 M | 5.9 M | 32 M | 36.9 M | 40.4 M | 43.2 M | 45.3 M |
LeMaitre Vascular and related stocks such as InfuSystems Holdings, Pro Dex, and Utah Medical Products Other Stockholder Equity description
My Equities
My Current Equities and Potential Positions
| LeMaitre Vascular | LMAT |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 105.43
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.